---
document_datetime: 2025-10-02 15:34:48
document_pages: 1
document_pathfilename: www.ema.europa.eu/en/documents/all-authorised-presentations/tyenne-epar-all-authorised-presentations_en.pdf
document_name: tyenne-epar-all-authorised-presentations_en.pdf
version: success
processing_time: 1.5844654
conversion_datetime: 2025-12-23 05:09:58.655447
docling_version:
  docling-serve: 1.9.0
  docling-jobkit: 1.8.0
  docling: 2.64.1
  docling-core: 2.55.0
  docling-ibm-models: 3.10.3
  docling-parse: 4.7.2
  python: cpython-313 (3.13.11)
  plaform: macOS-26.2-arm64-arm-64bit-Mach-O
---
## EMA (EU) Number (Invented) name Strength Pharmaceutical Form Route of Administration Immediate Packaging Content (concentration) Pack size

| EU/1/23/1754/001   | Tyenne   | 20 mg/ml   | Concentrate for solution for infusion   | Intravenous use   | vial (glass)                                    | 4 ml               | 1 vial                                  |
|--------------------|----------|------------|-----------------------------------------|-------------------|-------------------------------------------------|--------------------|-----------------------------------------|
| EU/1/23/1754/002   | Tyenne   | 20 mg/ml   | Concentrate for solution for infusion   | Intravenous use   | vial (glass)                                    | 4 ml               | 4 vials                                 |
| EU/1/23/1754/003   | Tyenne   | 20 mg/ml   | Concentrate for solution for infusion   | Intravenous use   | vial (glass)                                    | 10 ml              | 1 vial                                  |
| EU/1/23/1754/004   | Tyenne   | 20 mg/ml   | Concentrate for solution for infusion   | Intravenous use   | vial (glass)                                    | 10 ml              | 4 vials                                 |
| EU/1/23/1754/005   | Tyenne   | 20 mg/ml   | Concentrate for solution for infusion   | Intravenous use   | vial (glass)                                    | 20 ml              | 1 vial                                  |
| EU/1/23/1754/006   | Tyenne   | 20 mg/ml   | Concentrate for solution for infusion   | Intravenous use   | vial (glass)                                    | 20 ml              | 4 vials                                 |
| EU/1/23/1754/007   | Tyenne   | 162 mg     | Solution for injection                  | Subcutaneous use  | pre-filled syringe (glass)                      | 0.9 ml (180 mg/ml) | 1 pre-filled syringe                    |
| EU/1/23/1754/008   | Tyenne   | 162 mg     | Solution for injection                  | Subcutaneous use  | pre-filled syringe (glass)                      | 0.9 ml (180 mg/ml) | 4 pre-filled syringes                   |
| EU/1/23/1754/009   | Tyenne   | 162 mg     | Solution for injection                  | Subcutaneous use  | pre-filled syringe (glass)                      | 0.9 ml (180 mg/ml) | 12 pre-filled syringes                  |
| EU/1/23/1754/010   | Tyenne   | 162 mg     | Solution for injection                  | Subcutaneous use  | pre-filled syringe (glass) in a pre- filled pen | 0.9 ml (180 mg/ml) | 1 pre-filled pen                        |
| EU/1/23/1754/011   | Tyenne   | 162 mg     | Solution for injection                  | Subcutaneous use  | pre-filled syringe (glass) in a pre- filled pen | 0.9 ml (180 mg/ml) | 4 pre-filled pens                       |
| EU/1/23/1754/012   | Tyenne   | 162 mg     | Solution for injection                  | Subcutaneous use  | pre-filled syringe (glass) in a pre- filled pen | 0.9 ml (180 mg/ml) | 12 (3 x 4) pre- filled pens (multipack) |